The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Expression Competent Cells-Global Market Insights and Sales Trends 2024
Synopsis
The Protein Expression Competent Cell Pack lets you efficiently economically optimize expression by simultaneously testing multiple strains with your gene of interest. The pack includes BL21(DE3) competent cells for nontoxic proteins and BL21(DE3) pLysS competent cells for both toxic and nontoxic proteins.
The global Expression Competent Cells market size is expected to reach US$ 746.9 million by 2029, growing at a CAGR of 10.1% from 2023 to 2029. The market is mainly driven by the significant applications of Expression Competent Cells in various end use industries. The expanding demands from the Protein Expression and Other, are propelling Expression Competent Cells market. Chemically Competent Cells, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Electrocompetent Cells segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Expression Competent Cells market, driven by demand from China, the second largest economy with some signs of stabilising, the Expression Competent Cells market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Expression Competent Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Expression Competent Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Expression Competent Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Expression Competent Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Expression Competent Cells covered in this report include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc.
The global Expression Competent Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Global Expression Competent Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Expression Competent Cells market, Segment by Type:
Chemically Competent Cells
Electrocompetent Cells
Global Expression Competent Cells market, by Application
Protein Expression
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Expression Competent Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The Protein Expression Competent Cell Pack lets you efficiently economically optimize expression by simultaneously testing multiple strains with your gene of interest. The pack includes BL21(DE3) competent cells for nontoxic proteins and BL21(DE3) pLysS competent cells for both toxic and nontoxic proteins.
The global Expression Competent Cells market size is expected to reach US$ 746.9 million by 2029, growing at a CAGR of 10.1% from 2023 to 2029. The market is mainly driven by the significant applications of Expression Competent Cells in various end use industries. The expanding demands from the Protein Expression and Other, are propelling Expression Competent Cells market. Chemically Competent Cells, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Electrocompetent Cells segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Expression Competent Cells market, driven by demand from China, the second largest economy with some signs of stabilising, the Expression Competent Cells market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Expression Competent Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Expression Competent Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Expression Competent Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Expression Competent Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Expression Competent Cells covered in this report include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc.
The global Expression Competent Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Global Expression Competent Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Expression Competent Cells market, Segment by Type:
Chemically Competent Cells
Electrocompetent Cells
Global Expression Competent Cells market, by Application
Protein Expression
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Expression Competent Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Expression Competent Cells
1.1 Expression Competent Cells Market Overview
1.1.1 Expression Competent Cells Product Scope
1.1.2 Expression Competent Cells Market Status and Outlook
1.2 Global Expression Competent Cells Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Expression Competent Cells Market Size by Region (2018-2029)
1.4 Global Expression Competent Cells Historic Market Size by Region (2018-2023)
1.5 Global Expression Competent Cells Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Expression Competent Cells Market Size (2018-2029)
1.6.1 North America Expression Competent Cells Market Size (2018-2029)
1.6.2 Europe Expression Competent Cells Market Size (2018-2029)
1.6.3 Asia-Pacific Expression Competent Cells Market Size (2018-2029)
1.6.4 Latin America Expression Competent Cells Market Size (2018-2029)
1.6.5 Middle East & Africa Expression Competent Cells Market Size (2018-2029)
2 Expression Competent Cells Market by Type
2.1 Introduction
2.1.1 Chemically Competent Cells
2.1.2 Electrocompetent Cells
2.2 Global Expression Competent Cells Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Expression Competent Cells Historic Market Size by Type (2018-2023)
2.2.2 Global Expression Competent Cells Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Expression Competent Cells Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Expression Competent Cells Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Expression Competent Cells Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Expression Competent Cells Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Expression Competent Cells Revenue Breakdown by Type (2018-2029)
3 Expression Competent Cells Market Overview by Application
3.1 Introduction
3.1.1 Protein Expression
3.1.2 Other
3.2 Global Expression Competent Cells Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Expression Competent Cells Historic Market Size by Application (2018-2023)
3.2.2 Global Expression Competent Cells Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Expression Competent Cells Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Expression Competent Cells Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Expression Competent Cells Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Expression Competent Cells Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Expression Competent Cells Revenue Breakdown by Application (2018-2029)
4 Expression Competent Cells Competition Analysis by Players
4.1 Global Expression Competent Cells Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Expression Competent Cells as of 2022)
4.3 Date of Key Players Enter into Expression Competent Cells Market
4.4 Global Top Players Expression Competent Cells Headquarters and Area Served
4.5 Key Players Expression Competent Cells Product Solution and Service
4.6 Competitive Status
4.6.1 Expression Competent Cells Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck KGaA
5.1.1 Merck KGaA Profile
5.1.2 Merck KGaA Main Business
5.1.3 Merck KGaA Expression Competent Cells Products, Services and Solutions
5.1.4 Merck KGaA Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.1.5 Merck KGaA Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Expression Competent Cells Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Agilent Technologies
5.3.1 Agilent Technologies Profile
5.3.2 Agilent Technologies Main Business
5.3.3 Agilent Technologies Expression Competent Cells Products, Services and Solutions
5.3.4 Agilent Technologies Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.3.5 Takara Bio Recent Developments
5.4 Takara Bio
5.4.1 Takara Bio Profile
5.4.2 Takara Bio Main Business
5.4.3 Takara Bio Expression Competent Cells Products, Services and Solutions
5.4.4 Takara Bio Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.4.5 Takara Bio Recent Developments
5.5 Promega Corporation
5.5.1 Promega Corporation Profile
5.5.2 Promega Corporation Main Business
5.5.3 Promega Corporation Expression Competent Cells Products, Services and Solutions
5.5.4 Promega Corporation Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.5.5 Promega Corporation Recent Developments
5.6 Beijing TransGen Biotech
5.6.1 Beijing TransGen Biotech Profile
5.6.2 Beijing TransGen Biotech Main Business
5.6.3 Beijing TransGen Biotech Expression Competent Cells Products, Services and Solutions
5.6.4 Beijing TransGen Biotech Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.6.5 Beijing TransGen Biotech Recent Developments
5.7 GeneScript Corporation
5.7.1 GeneScript Corporation Profile
5.7.2 GeneScript Corporation Main Business
5.7.3 GeneScript Corporation Expression Competent Cells Products, Services and Solutions
5.7.4 GeneScript Corporation Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.7.5 GeneScript Corporation Recent Developments
5.8 Yeastern Biotech
5.8.1 Yeastern Biotech Profile
5.8.2 Yeastern Biotech Main Business
5.8.3 Yeastern Biotech Expression Competent Cells Products, Services and Solutions
5.8.4 Yeastern Biotech Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.8.5 Yeastern Biotech Recent Developments
5.9 New England Biolabs
5.9.1 New England Biolabs Profile
5.9.2 New England Biolabs Main Business
5.9.3 New England Biolabs Expression Competent Cells Products, Services and Solutions
5.9.4 New England Biolabs Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.9.5 New England Biolabs Recent Developments
5.10 QIAGEN N.V.
5.10.1 QIAGEN N.V. Profile
5.10.2 QIAGEN N.V. Main Business
5.10.3 QIAGEN N.V. Expression Competent Cells Products, Services and Solutions
5.10.4 QIAGEN N.V. Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.10.5 QIAGEN N.V. Recent Developments
5.11 OriGene Technologies
5.11.1 OriGene Technologies Profile
5.11.2 OriGene Technologies Main Business
5.11.3 OriGene Technologies Expression Competent Cells Products, Services and Solutions
5.11.4 OriGene Technologies Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.11.5 OriGene Technologies Recent Developments
5.12 Lucigen
5.12.1 Lucigen Profile
5.12.2 Lucigen Main Business
5.12.3 Lucigen Expression Competent Cells Products, Services and Solutions
5.12.4 Lucigen Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.12.5 Lucigen Recent Developments
5.13 Zymo Research
5.13.1 Zymo Research Profile
5.13.2 Zymo Research Main Business
5.13.3 Zymo Research Expression Competent Cells Products, Services and Solutions
5.13.4 Zymo Research Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.13.5 Zymo Research Recent Developments
5.14 Bio-Rad Laboratories
5.14.1 Bio-Rad Laboratories Profile
5.14.2 Bio-Rad Laboratories Main Business
5.14.3 Bio-Rad Laboratories Expression Competent Cells Products, Services and Solutions
5.14.4 Bio-Rad Laboratories Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.14.5 Bio-Rad Laboratories Recent Developments
5.15 Bioline
5.15.1 Bioline Profile
5.15.2 Bioline Main Business
5.15.3 Bioline Expression Competent Cells Products, Services and Solutions
5.15.4 Bioline Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.15.5 Bioline Recent Developments
5.16 Delphi Genetics
5.16.1 Delphi Genetics Profile
5.16.2 Delphi Genetics Main Business
5.16.3 Delphi Genetics Expression Competent Cells Products, Services and Solutions
5.16.4 Delphi Genetics Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.16.5 Delphi Genetics Recent Developments
5.17 IBA GmBH
5.17.1 IBA GmBH Profile
5.17.2 IBA GmBH Main Business
5.17.3 IBA GmBH Expression Competent Cells Products, Services and Solutions
5.17.4 IBA GmBH Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.17.5 IBA GmBH Recent Developments
5.18 Cell Applications
5.18.1 Cell Applications Profile
5.18.2 Cell Applications Main Business
5.18.3 Cell Applications Expression Competent Cells Products, Services and Solutions
5.18.4 Cell Applications Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.18.5 Cell Applications Recent Developments
5.19 BioDynamics Laboratory
5.19.1 BioDynamics Laboratory Profile
5.19.2 BioDynamics Laboratory Main Business
5.19.3 BioDynamics Laboratory Expression Competent Cells Products, Services and Solutions
5.19.4 BioDynamics Laboratory Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.19.5 BioDynamics Laboratory Recent Developments
5.20 Scarab Genomics
5.20.1 Scarab Genomics Profile
5.20.2 Scarab Genomics Main Business
5.20.3 Scarab Genomics Expression Competent Cells Products, Services and Solutions
5.20.4 Scarab Genomics Expression Competent Cells Revenue (US$ Million) & (2018-2023)
5.20.5 Scarab Genomics Recent Developments
6 North America
6.1 North America Expression Competent Cells Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Expression Competent Cells Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Expression Competent Cells Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Expression Competent Cells Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Expression Competent Cells Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Expression Competent Cells Market Dynamics
11.1 Expression Competent Cells Industry Trends
11.2 Expression Competent Cells Market Drivers
11.3 Expression Competent Cells Market Challenges
11.4 Expression Competent Cells Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
